These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25962692)

  • 61. Hepatitis B screening before chemotherapy: a survey of practitioners' knowledge, beliefs, and screening practices.
    Lee RS; Bell CM; Singh JM; Hicks LK
    J Oncol Pract; 2012 Nov; 8(6):325-8, 1 p following 328. PubMed ID: 23598840
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Trends in hepatitis B virus screening at the onset of chemotherapy in a large US cancer center.
    Hwang JP; Fisch MJ; Lok AS; Zhang H; Vierling JM; Suarez-Almazor ME
    BMC Cancer; 2013 Nov; 13():534. PubMed ID: 24209764
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Health Screening among HBV Carriers in the Korean National Health and Nutrition Examination Survey V (KNHANES V).
    Son HE; Jung SJ; Shin A
    Asian Pac J Cancer Prev; 2015; 16(9):3653-7. PubMed ID: 25987017
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cost-effectiveness of Hepatitis B Virus Infection Screening and Treatment or Vaccination in 6 High-risk Populations in the United States.
    Chahal HS; Peters MG; Harris AM; McCabe D; Volberding P; Kahn JG
    Open Forum Infect Dis; 2019 Jan; 6(1):ofy353. PubMed ID: 30931346
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hepatitis B immunization in a low-incidence province of Canada: comparing alternative strategies.
    Wiebe T; Fergusson P; Horne D; Shanahan M; Macdonald A; Heise L; Roos LL
    Med Decis Making; 1997; 17(4):472-82. PubMed ID: 9343806
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Budget impact analysis on the introduction of a guideline based hepatitis B and C screening into a routine check-up in the German primary care setting.
    Barth C; Neusser S; Biermann J; Wasem J; Berg T; Wiegand J; Wolffram I; Petroff D; Aidelsburger P; Grünbauer A; Neumann A
    Scand J Gastroenterol; 2018 Jan; 53(1):76-82. PubMed ID: 29065740
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Impact and Cost-Effectiveness of Biomedical Interventions on Adult Hepatitis B Elimination in China: A Mathematical Modelling Study.
    Wang X; Du Z; Wang Y; Wang J; Huang S; Wang Y; Gu J; Deng W; Gilmour S; Li J; Hao Y
    J Epidemiol Glob Health; 2023 Sep; 13(3):517-527. PubMed ID: 37349664
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cost-effectiveness of treating all hepatitis B-positive individuals in the United States.
    Razavi-Shearer D; Estes C; Gamkrelidze I; Razavi H
    J Viral Hepat; 2023 Sep; 30(9):718-726. PubMed ID: 37260095
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Economic evaluation of implementing a decentralised Hepatitis B virus diagnostic intervention under National Viral Hepatitis Control Programme in Tamil Nadu, South India.
    Muniyandi M; Tyagi K; Singh M; Prakash V; Karikalan N; Senthilkumar S; Karthikeyan S; Krishnan R; Rajsekar K; Shanmugam V; Selvavinayagam TS
    Trop Med Int Health; 2021 Mar; 26(3):374-384. PubMed ID: 33190357
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cost-effectiveness analysis of prenatal screening and vaccination against hepatitis B virus--the case of Belgium.
    Tormans G; Van Damme P; Carrin G; Clara R; Eylenbosch W
    Soc Sci Med; 1993 Jul; 37(2):173-81. PubMed ID: 8351532
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Effectiveness and Cost-Effectiveness of Screening for and Vaccination Against Hepatitis B Virus among Migrants in the EU/EEA: A Systematic Review.
    Myran DT; Morton R; Biggs BA; Veldhuijzen I; Castelli F; Tran A; Staub LP; Agbata E; Rahman P; Pareek M; Noori T; Pottie K
    Int J Environ Res Public Health; 2018 Sep; 15(9):. PubMed ID: 30200406
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cost-effectiveness of different monitoring strategies in a screening and treatment programme for hepatitis B in The Gambia.
    Schmit N; Nayagam S; Lemoine M; Ndow G; Shimakawa Y; Thursz MR; Hallett TB
    J Glob Health; 2023 Jan; 13():04004. PubMed ID: 36655869
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Expanding Antiviral Prophylaxis During Pregnancy to Prevent Perinatal Hepatitis B Virus Infection: A Cost-effectiveness Study.
    Du J; Wang Z; Wu B
    Open Forum Infect Dis; 2020 May; 7(5):ofaa137. PubMed ID: 32478119
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A survey of clinical practices among oncologists regarding hepatitis B screening in patients with cancer.
    Sundaram S; Patil P; Sengar M; Rathod R; Mehta S
    Indian J Med Res; 2020 Jun; 151(6):604-608. PubMed ID: 32719235
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The emergency department as a setting-specific opportunity for population-based hepatitis C screening: An economic evaluation.
    Mendlowitz AB; Naimark D; Wong WWL; Capraru C; Feld JJ; Isaranuwatchai W; Krahn M
    Liver Int; 2020 Jun; 40(6):1282-1291. PubMed ID: 32267604
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Chronic hepatitis B virus infection: issues in treatment.
    O'Shea R
    Cleve Clin J Med; 2007 Aug; 74(8):557-60. PubMed ID: 17708126
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical practice of hepatitis B screening in patients starting with chemotherapy: A survey among Dutch oncologists.
    Leber K; Otten HJMMB; Brandjes DPM; Claassen MAA; Lauw FN
    Eur J Cancer Care (Engl); 2021 Nov; 30(6):e13495. PubMed ID: 34310787
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cost-Effectiveness of HBV and HCV Screening Strategies--A Systematic Review of Existing Modelling Techniques.
    Geue C; Wu O; Xin Y; Heggie R; Hutchinson S; Martin NK; Fenwick E; Goldberg D; ;
    PLoS One; 2015; 10(12):e0145022. PubMed ID: 26689908
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Screening for viral hepatitis B infection in cancer patients before receiving chemotherapy - A systematic review and meta-analysis.
    Maung ST; Deepan N; Decharatanachart P; Chaiteerakij R
    Asia Pac J Clin Oncol; 2024 Jun; 20(3):335-345. PubMed ID: 38512893
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cost-effectiveness of managing HBV reactivation in patients with resolved HBV infection treated with anti-CD20 antibody for B-cell non-Hodgkin lymphoma.
    Fujita M; Kusumoto S; Ishii I; Iwata T; Fujisawa T; Sugiyama M; Hata A; Mizokami M
    Sci Rep; 2022 May; 12(1):7365. PubMed ID: 35513395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.